PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 30 filers reported holding PROTEON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $346,000 | +73.0% | 844,122 | +10.0% | 0.00% | – |
| Q3 2019 | $200,000 | -31.5% | 767,422 | +9.2% | 0.00% | – |
| Q2 2019 | $292,000 | +27.5% | 702,922 | +54.2% | 0.00% | – |
| Q1 2019 | $229,000 | -68.3% | 455,744 | +43.0% | 0.00% | -100.0% |
| Q4 2018 | $723,000 | +10.2% | 318,619 | -5.3% | 0.00% | 0.0% |
| Q3 2018 | $656,000 | -51.1% | 336,408 | -38.0% | 0.00% | 0.0% |
| Q2 2018 | $1,341,000 | +127.3% | 542,581 | +129.8% | 0.00% | 0.0% |
| Q1 2018 | $590,000 | +54.0% | 236,100 | +17.2% | 0.00% | – |
| Q4 2017 | $383,000 | +11.3% | 201,500 | +17.2% | 0.00% | – |
| Q3 2017 | $344,000 | +82.0% | 171,900 | +38.4% | 0.00% | – |
| Q2 2017 | $189,000 | +105.4% | 124,200 | +136.6% | 0.00% | – |
| Q1 2017 | $92,000 | +58.6% | 52,500 | +72.1% | 0.00% | – |
| Q4 2016 | $58,000 | – | 30,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 315,101 | $599,000 | 25.51% |
| Abingworth LLP | 2,017,872 | $3,632,000 | 3.04% |
| Pharmstandard International S.A. | 1,165,344 | $2,214,000 | 1.91% |
| MPM ASSET MANAGEMENT LLC | 983,381 | $1,868,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,332,599 | $2,532,000 | 0.10% |
| Perceptive Advisors | 334,116 | $635,000 | 0.04% |
| Baker Brothers Advisors | 389,394 | $740,000 | 0.01% |
| WEDBUSH SECURITIES INC | 17,000 | $32,000 | 0.01% |
| FINANCIAL COUNSELORS INC | 50,000 | $95,000 | 0.01% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 11,499 | $21,000 | 0.00% |